Oncology Data Advisor

Analyzing Enzalutamide Patient-Reported Outcomes and QOL in the EMBARK Trial: Stephen Freedland, MD

Informações:

Synopsis

This playlist features interviews recorded live by Oncology Data Advisor at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting in Chicago. Visit oncdata.com to learn more!